PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Detail   |   Print    Next page > 
     
From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery
2026-05-28T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
Ribo Announces Phase 2 Clinical Trial Submission to EMA, Further Advancing siRNA Therapeutics in Thromboembolic Disease
2026-05-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery
2026-05-28T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
Antengene Receives CDE Endorsement to Initiate Pivotal Phase III CLINCH-3 Study of ATG-022 in CLDN18.2+ Advanced Gastric/GEJ Cancer
2026-05-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions' SPOT-MAS 10 Multi-Cancer Screening Test
2026-05-28T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
HEALEY ALS Platform Trial Regimen I expands to 240 participants
2026-05-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Want to Stay Current on Latest in Cancer Prevention and Treatment? Free Service from NCCN Can Help
2026-05-27T    Health Care/Hospital   Medical/Pharmaceuticals 
Metabolon Expands Global Access to Metabolomics with the Metabolon Verus™ Metabolomics Profiling Kit
2026-05-27T    Computer/Electronics   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery
2026-05-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery
2026-05-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.